Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease

S. D. Shapiro
European Respiratory Journal 2007 29: 375-378; DOI: 10.1183/09031936.00087606
S. D. Shapiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Fig. 1—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1—

    Factors resulting in airspace enlargement in mice. Mice may obtain enlarged airspaces due to abnormal development or destruction of mature alveoli. Failed septation during alveogenesis occurring in transgenic mice might have biological importance if the overexpressed protein has the capacity to be overexpressed in human lung development. Abnormal alveogenesis in knockout mice suggests that the product is made and if, for some reason, lost, this could result in disease. Neither mechanism is directly relevant to pulmonary emphysema, which is defined by destruction of airspaces that were previously normal. This phenotype may be observed in mice via one of the following: by inducing a transgene during adulthood, spontaneous occurrence over time in gene-targeted mice, and by administering a relevant injurious agent (e.g. cigarette smoke) to gene-targeted mice. The mice can then be compared with wildtype mice to determine a role in chronic obstructive pulmonary disease.

PreviousNext
Back to top
View this article with LENS
Vol 29 Issue 2 Table of Contents
European Respiratory Journal: 29 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease
S. D. Shapiro
European Respiratory Journal Feb 2007, 29 (2) 375-378; DOI: 10.1183/09031936.00087606

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease
S. D. Shapiro
European Respiratory Journal Feb 2007, 29 (2) 375-378; DOI: 10.1183/09031936.00087606
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • TRANSGENIC MICE
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The management of mild asthma
  • Treatment options in type-2 low asthma
  • Trends in worldwide asthma prevalence
Show more Series

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society